Stay updated on Magrolimab vs. Venetoclax in TP53 AML Clinical Trial

Sign up to get notified when there's something new on the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T13:45:29.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page. This is a metadata version change and does not alter the study details displayed.
    Difference
    0.0%
    Check dated 2026-02-14T15:49:51.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1, replacing the previous Revision: v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-06T09:24:04.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    - Revision: v3.3.4 updated (replacing v3.3.3). The overall study information on the page remains unchanged.
    Difference
    0.0%
    Check dated 2026-01-15T04:19:08.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a Locations section with a comprehensive list of study sites across the US and Australia; previous location entries were removed.
    Difference
    1%
    Check dated 2025-12-24T16:28:13.000Z thumbnail image
  8. Check
    112 days ago
    Change Detected
    Summary
    Publications note updated to say PubMed publications are automatically filled from PubMed, and the revision tag changed from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T14:51:55.000Z thumbnail image

Stay in the know with updates to Magrolimab vs. Venetoclax in TP53 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page.